Wellspring Ophthalmics Announces Receiving Its Second Patent for Novel Cyclosporine Dry Eye Therapy
Company Remains Focused on Finding a Licensee for This Proprietary Cyclosporine Platform and is Encouraged by the Significant Interest to Date MISSION VIEJO, Calif.–(BUSINESS WIRE)–Today, Wellspring Ophthalmics, a Mission Viejo-based development stage eye care pharmaceutical company focused on innovating an improved, effective dry eye therapy, announces receiving its second patent for a novel cyclosporine dry … [Read more…]
